![A1AOA A1AOA](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AOA.svg) | A1AOA | 表記: | 7-[(1S)-1-{[(5R,8S)-10-acetyl-6,7,8,9-tetrahydro-5H-5,8-epiminocyclohepta[d]pyrimidin-4-yl]amino}-2-methylpropyl]-3,4-dihydro-1lambda~6~-benzothiopyran-1,1(2H)-dione | 組成式: | C24 H30 N4 O3 S | SMILES: | CC(=O)N1C2CCC1Cc1ncnc(NC(c3ccc4CCCS(=O)(=O)c4c3)C(C)C)c21 | InChi: | InChI=1S/C24H30N4O3S/c1-14(2)23(17-7-6-16-5-4-10-32(30,31)21(16)11-17)27-24-22-19(25-13-26-24)12-18-8-9-20(22)28(18)15(3)29/h6-7,11,13-14,18,20,23H,4-5,8-10,12H2,1-3H3,(H,25,26,27)/t18-,20+,23-/m0/s1 | 定義日: | 2024-04-18 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | 7-[(1S)-1-{[(5R,8S)-10-acetyl-6,7,8,9-tetrahydro-5H-5,8-epiminocyclohepta[d]pyrimidin-4-yl]amino}-2-methylpropyl]-3,4-dihydro-1lambda~6~-benzothiopyran-1,1(2H)-dione |
|
![A1AOB A1AOB](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AOB.svg) | A1AOB | 表記: | 4-{[(1R)-1-(1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~-benzothiopyran-7-yl)-2-methylpropyl]amino}-N-[(3R)-1-methylpyrrolidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 組成式: | C25 H32 N6 O3 S | SMILES: | CN1CCC(C1)NC(=O)c1cc2c([NH]1)ncnc2NC(c1ccc2CCCS(=O)(=O)c2c1)C(C)C | InChi: | InChI=1S/C25H32N6O3S/c1-15(2)22(17-7-6-16-5-4-10-35(33,34)21(16)11-17)30-24-19-12-20(29-23(19)26-14-27-24)25(32)28-18-8-9-31(3)13-18/h6-7,11-12,14-15,18,22H,4-5,8-10,13H2,1-3H3,(H,28,32)(H2,26,27,29,30)/t18-,22-/m1/s1 | 定義日: | 2024-04-18 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | 4-{[(1R)-1-(1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~-benzothiopyran-7-yl)-2-methylpropyl]amino}-N-[(3R)-1-methylpyrrolidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide |
|
![A1AQV A1AQV](https://data.pdbj.org/pdbjplus/data/cc/svg/A1AQV.svg) | A1AQV | 表記: | chlordecone | 組成式: | C10 H2 Cl10 O2 | SMILES: | ClC12C3(Cl)C4(Cl)C5(Cl)C3(Cl)C(O)(O)C1(Cl)C5(Cl)C2(Cl)C4(Cl)Cl | InChi: | InChI=1S/C10H2Cl10O2/c11-1-2(12)6(16)4(14)3(13,5(1,15)9(6,19)20)7(1,17)10(21,22)8(2,4)18/h21-22H/t1-,2+,3+,4-,5+,6-,7-,8+ | 別名: | (1R,1as,3s,3aR,4r,5ar,5bS,6S)-1,1a,3,3a,4,5,5,5a,5b,6-decachlorooctahydro-2H-1,3,4-(methanetriyl)cyclobuta[cd]pentalene-2,2-diol | 定義日: | 2024-05-06 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | (1R,1as,3s,3aR,4r,5ar,5bS,6S)-1,1a,3,3a,4,5,5,5a,5b,6-decachlorooctahydro-2H-1,3,4-(methanetriyl)cyclobuta[cd]pentalene-2,2-diol |
|
![A1H09 A1H09](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H09.svg) | A1H09 | 表記: | Haemophilus influenzae type b (Hib) DP3 oligosaccharide | 組成式: | C30 H59 O34 P3 | SMILES: | OC[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[CH]1[CH](O)[CH](OC[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[CH]2[CH](O)[CH](OC[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[CH]3[CH](O)[CH](O)O[CH]3CO)O[CH]2CO)O[CH]1CO | InChi: | InChI=1S/C30H59O34P3/c31-1-10(35)19(41)13(38)7-56-66(50,51)63-26-17(3-33)60-29(23(26)45)55-6-12(37)21(43)15(40)9-58-67(52,53)64-27-18(4-34)61-30(24(27)46)54-5-11(36)20(42)14(39)8-57-65(48,49)62-25-16(2-32)59-28(47)22(25)44/h10-47H,1-9H2,(H,48,49)(H,50,51)(H,52,53)/t10-,11-,12-,13+,14+,15+,16+,17+,18+,19-,20-,21-,22+,23+,24+,25+,26+,27+,28+,29+,30+/m0/s1 | 別名: | [(2~{R},3~{S},4~{R},5~{R})-2-(hydroxymethyl)-4,5-bis(oxidanyl)oxolan-3-yl] [(2~{R},3~{S},4~{S})-5-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-4-[[(2~{R},3~{S},4~{S})-5-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3-oxidanyl-4-[oxidanyl-[(2~{R},3~{S},4~{S})-2,3,4,5-tetrakis(oxidanyl)pentoxy]phosphoryl]oxy-oxolan-2-yl]oxy-2,3,4-tris(oxidanyl)pentoxy]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]oxy-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate | 定義日: | 2023-12-21 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | [(2~{R},3~{S},4~{R},5~{R})-2-(hydroxymethyl)-4,5-bis(oxidanyl)oxolan-3-yl] [(2~{R},3~{S},4~{S})-5-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-4-[[(2~{R},3~{S},4~{S})-5-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3-oxidanyl-4-[oxidanyl-[(2~{R},3~{S},4~{S})-2,3,4,5-tetrakis(oxidanyl)pentoxy]phosphoryl]oxy-oxolan-2-yl]oxy-2,3,4-tris(oxidanyl)pentoxy]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]oxy-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate |
|
![A1H0Z A1H0Z](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H0Z.svg) | A1H0Z | 表記: | D-Ribitol-5-phosphate | 組成式: | C5 H13 O8 P | SMILES: | OC[CH](O)[CH](O)[CH](O)CO[P](O)(O)=O | InChi: | InChI=1S/C5H13O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h3-9H,1-2H2,(H2,10,11,12)/t3-,4+,5-/m0/s1 | 別名: | [(2R,3S,4S)-2,3,4,5-tetrakis(oxidanyl)pentyl] dihydrogen phosphate | 定義日: | 2023-12-20 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | [(2~{R},3~{S},4~{S})-2,3,4,5-tetrakis(oxidanyl)pentyl] dihydrogen phosphate |
|
![A1H1A A1H1A](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H1A.svg) | A1H1A | 表記: | Haemophilus influenzae type b (Hib) DP2 oligosaccharide | 組成式: | C20 H40 O23 P2 | SMILES: | OC[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[CH]1[CH](O)[CH](OC[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[CH]2[CH](O)[CH](O)O[CH]2CO)O[CH]1CO | InChi: | InChI=1S/C20H40O23P2/c21-1-7(24)13(28)9(26)5-38-45(35,36)43-18-12(3-23)41-20(16(18)31)37-4-8(25)14(29)10(27)6-39-44(33,34)42-17-11(2-22)40-19(32)15(17)30/h7-32H,1-6H2,(H,33,34)(H,35,36)/t7-,8-,9+,10+,11+,12+,13-,14-,15+,16+,17+,18+,19+,20+/m0/s1 | 別名: | [(2~{R},3~{S},4~{R},5~{R})-2-(hydroxymethyl)-4,5-bis(oxidanyl)oxolan-3-yl] [(2~{R},3~{S},4~{S})-5-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3-oxidanyl-4-[oxidanyl-[(2~{R},3~{S},4~{S})-2,3,4,5-tetrakis(oxidanyl)pentoxy]phosphoryl]oxy-oxolan-2-yl]oxy-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate | 定義日: | 2023-12-21 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | [(2~{R},3~{S},4~{R},5~{R})-2-(hydroxymethyl)-4,5-bis(oxidanyl)oxolan-3-yl] [(2~{R},3~{S},4~{S})-5-[(2~{R},3~{R},4~{S},5~{R})-5-(hydroxymethyl)-3-oxidanyl-4-[oxidanyl-[(2~{R},3~{S},4~{S})-2,3,4,5-tetrakis(oxidanyl)pentoxy]phosphoryl]oxy-oxolan-2-yl]oxy-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate |
|
![A1H3V A1H3V](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H3V.svg) | A1H3V | 表記: | (3~{a}~{R},4~{R},5~{R},6~{R},7~{a}~{S})-6-(hydroxymethyl)-4,5-bis(oxidanyl)-3~{a},4,5,6,7,7~{a}-hexahydro-3~{H}-1,3-benzoxazol-2-one | 組成式: | C8 H13 N O5 | SMILES: | OC[CH]1C[CH]2OC(=O)N[CH]2[CH](O)[CH]1O | InChi: | InChI=1S/C8H13NO5/c10-2-3-1-4-5(7(12)6(3)11)9-8(13)14-4/h3-7,10-12H,1-2H2,(H,9,13)/t3-,4+,5+,6-,7-/m1/s1 | 別名: | alpha-1,2-cyclophellitol analogue | 定義日: | 2024-02-07 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | (3~{a}~{R},4~{R},5~{R},6~{R},7~{a}~{S})-6-(hydroxymethyl)-4,5-bis(oxidanyl)-3~{a},4,5,6,7,7~{a}-hexahydro-3~{H}-1,3-benzoxazol-2-one |
|
![A1H4F A1H4F](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H4F.svg) | A1H4F | 表記: | (2S)-2-[2-[4-[[(2R,3S,4S)-3-acetyloxy-4-oxidanyl-pyrrolidin-2-yl]methyl]phenoxy]ethanoylamino]-6-azanyl-hexanoic acid | 組成式: | C21 H31 N3 O7 | SMILES: | CC(=O)O[CH]1[CH](O)CN[CH]1Cc2ccc(OCC(=O)N[CH](CCCCN)C(O)=O)cc2 | InChi: | InChI=1S/C21H31N3O7/c1-13(25)31-20-17(23-11-18(20)26)10-14-5-7-15(8-6-14)30-12-19(27)24-16(21(28)29)4-2-3-9-22/h5-8,16-18,20,23,26H,2-4,9-12,22H2,1H3,(H,24,27)(H,28,29)/t16-,17+,18-,20-/m0/s1 | 定義日: | 2024-02-14 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | (2~{S})-2-[2-[4-[[(2~{R},3~{S},4~{S})-3-acetyloxy-4-oxidanyl-pyrrolidin-2-yl]methyl]phenoxy]ethanoylamino]-6-azanyl-hexanoic acid |
|
![A1H5V A1H5V](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H5V.svg) | A1H5V | 表記: | 5-chloranyl-2-ethoxy-4-fluoranyl-~{N}-[4-[[3-(methoxymethyl)-1-oxidanylidene-6,7-dihydro-5~{H}-pyrazolo[1,2-a][1,2]benzodiazepin-2-yl]amino]-2,2-dimethyl-4-oxidanylidene-butyl]benzamide | 組成式: | C29 H34 Cl F N4 O5 | SMILES: | CCOc1cc(F)c(Cl)cc1C(=O)NCC(C)(C)CC(=O)NC2=C(COC)N3CCCc4ccccc4N3C2=O | InChi: | InChI=1S/C29H34ClFN4O5/c1-5-40-24-14-21(31)20(30)13-19(24)27(37)32-17-29(2,3)15-25(36)33-26-23(16-39-4)34-12-8-10-18-9-6-7-11-22(18)35(34)28(26)38/h6-7,9,11,13-14H,5,8,10,12,15-17H2,1-4H3,(H,32,37)(H,33,36) | 定義日: | 2024-03-08 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | 5-chloranyl-2-ethoxy-4-fluoranyl-~{N}-[4-[[3-(methoxymethyl)-1-oxidanylidene-6,7-dihydro-5~{H}-pyrazolo[1,2-a][1,2]benzodiazepin-2-yl]amino]-2,2-dimethyl-4-oxidanylidene-butyl]benzamide |
|
![1XR 1XR](https://data.pdbj.org/pdbjplus/data/cc/svg/1XR.svg) | 1XR | 表記: | Bupropion | 組成式: | C13 H18 Cl N O | SMILES: | C[CH](NC(C)(C)C)C(=O)c1cccc(Cl)c1 | InChi: | InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3/t9-/m0/s1 | 別名: | Amfebutamone | 定義日: | 2022-11-17 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | (2~{S})-2-(~{tert}-butylamino)-1-(3-chlorophenyl)propan-1-one |
|
![A8J A8J](https://data.pdbj.org/pdbjplus/data/cc/svg/A8J.svg) | A8J | 表記: | tert-butyl 3-ethanoylbenzoate | 組成式: | C13 H16 O3 | SMILES: | CC(=O)c1cccc(c1)C(=O)OC(C)(C)C | InChi: | InChI=1S/C13H16O3/c1-9(14)10-6-5-7-11(8-10)12(15)16-13(2,3)4/h5-8H,1-4H3 | 別名: | 317829-73-5 | 定義日: | 2023-05-16 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | ~{tert}-butyl 3-ethanoylbenzoate |
|
![MWH MWH](https://data.pdbj.org/pdbjplus/data/cc/svg/MWH.svg) | MWH | 表記: | 4-[4-[(2~{S})-2-(2-chlorophenyl)pyrrolidin-1-yl]phenyl]-~{N}-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1~{H}-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | 組成式: | C42 H39 Cl N6 O7 S | SMILES: | [O-][N+](=O)c1cc(ccc1NCC2CCOCC2)[S](=O)(=O)NC(=O)c3ccc(cc3Oc4cnc5[nH]ccc5c4)c6ccc(cc6)N7CCC[CH]7c8ccccc8Cl | InChi: | InChI=1S/C42H39ClN6O7S/c43-36-5-2-1-4-34(36)38-6-3-19-48(38)31-10-7-28(8-11-31)29-9-13-35(40(23-29)56-32-22-30-15-18-44-41(30)46-26-32)42(50)47-57(53,54)33-12-14-37(39(24-33)49(51)52)45-25-27-16-20-55-21-17-27/h1-2,4-5,7-15,18,22-24,26-27,38,45H,3,6,16-17,19-21,25H2,(H,44,46)(H,47,50)/t38-/m0/s1 | 定義日: | 2023-01-05 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | 4-[4-[(2~{S})-2-(2-chlorophenyl)pyrrolidin-1-yl]phenyl]-~{N}-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1~{H}-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide |
|
![A1H97 A1H97](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H97.svg) | A1H97 | 表記: | (5~{R})-7-pyrazin-2-yl-2-oxa-7-azaspiro[4.4]nonane | 組成式: | C11 H15 N3 O | SMILES: | C1C[C]2(CCN(C2)c3cnccn3)CO1 | InChi: | InChI=1S/C11H15N3O/c1-5-14(10-7-12-3-4-13-10)8-11(1)2-6-15-9-11/h3-4,7H,1-2,5-6,8-9H2/t11-/m1/s1 | 定義日: | 2024-05-03 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | (5~{R})-7-pyrazin-2-yl-2-oxa-7-azaspiro[4.4]nonane |
|
![A1LZA A1LZA](https://data.pdbj.org/pdbjplus/data/cc/svg/A1LZA.svg) | A1LZA | 表記: | 5-[(2-methylphenyl)methyl]-11-(phenylmethyl)-2,5,7,11-tetrazatricyclo[7.4.0.0^{2,6}]trideca-1(9),6-dien-8-one | 組成式: | C24 H26 N4 O | SMILES: | Cc1ccccc1CN2CCN3C4=C(CN(CC4)Cc5ccccc5)C(=O)N=C23 | InChi: | InChI=1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-27-13-14-28-22-11-12-26(15-19-8-3-2-4-9-19)17-21(22)23(29)25-24(27)28/h2-10H,11-17H2,1H3 | 定義日: | 2024-03-16 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | 5-[(2-methylphenyl)methyl]-11-(phenylmethyl)-2,5,7,11-tetrazatricyclo[7.4.0.0^{2,6}]trideca-1(9),6-dien-8-one |
|
![AIE AIE](https://data.pdbj.org/pdbjplus/data/cc/svg/AIE.svg) | AIE | 表記: | 3-ethanoyl-N-phenyl-benzamide | 組成式: | C15 H13 N O2 | SMILES: | CC(=O)c1cccc(c1)C(=O)Nc2ccccc2 | InChi: | InChI=1S/C15H13NO2/c1-11(17)12-6-5-7-13(10-12)15(18)16-14-8-3-2-4-9-14/h2-10H,1H3,(H,16,18) | 別名: | AKOS000277907 | 定義日: | 2023-05-16 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | 3-ethanoyl-~{N}-phenyl-benzamide |
|
![AJF AJF](https://data.pdbj.org/pdbjplus/data/cc/svg/AJF.svg) | AJF | 表記: | methyl (2S)-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate | 組成式: | C19 H19 N O4 | SMILES: | COC(=O)[CH](Cc1ccccc1)NC(=O)c2cccc(c2)C(C)=O | InChi: | InChI=1S/C19H19NO4/c1-13(21)15-9-6-10-16(12-15)18(22)20-17(19(23)24-2)11-14-7-4-3-5-8-14/h3-10,12,17H,11H2,1-2H3,(H,20,22)/t17-/m0/s1 | 定義日: | 2023-05-16 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | methyl (2~{S})-2-[(3-ethanoylphenyl)carbonylamino]-3-phenyl-propanoate |
|
![IRY IRY](https://data.pdbj.org/pdbjplus/data/cc/svg/IRY.svg) | IRY | 表記: | [(2~{S})-2,3-bis(oxidanyl)propyl] 8-hexylselanyloctanoate | 組成式: | C17 H34 O4 Se | SMILES: | CCCCCC[Se]CCCCCCCC(=O)OC[CH](O)CO | InChi: | InChI=1S/C17H34O4Se/c1-2-3-4-9-12-22-13-10-7-5-6-8-11-17(20)21-15-16(19)14-18/h16,18-19H,2-15H2,1H3/t16-/m0/s1 | 定義日: | 2023-08-03 | 最終更新日: | 2024-05-10 | 公開日: | 2024-05-15 | 識別子(ID): | [(2~{S})-2,3-bis(oxidanyl)propyl] 8-hexylselanyloctanoate |
|
![ZY9 ZY9](https://data.pdbj.org/pdbjplus/data/cc/svg/ZY9.svg) | ZY9 | 表記: | 6-(aminomethyl)pyridine-2-carboxylic acid | 組成式: | C7 H8 N2 O2 | SMILES: | NCc1cccc(n1)C(O)=O | InChi: | InChI=1S/C7H8N2O2/c8-4-5-2-1-3-6(9-5)7(10)11/h1-3H,4,8H2,(H,10,11) | 定義日: | 2018-10-24 | 最終更新日: | 2024-05-09 | 公開日: | 2019-09-18 | 識別子(ID): | 6-(aminomethyl)pyridine-2-carboxylic acid |
|
![QUK QUK](https://data.pdbj.org/pdbjplus/data/cc/svg/QUK.svg) | QUK | 表記: | 8-azanyl-4-(3-azanylpropoxy)quinoline-2-carboxylic acid | 組成式: | C13 H15 N3 O3 | SMILES: | NCCCOc1cc(nc2c(N)cccc12)C(O)=O | InChi: | InChI=1S/C13H15N3O3/c14-5-2-6-19-11-7-10(13(17)18)16-12-8(11)3-1-4-9(12)15/h1,3-4,7H,2,5-6,14-15H2,(H,17,18) | 定義日: | 2016-05-24 | 最終更新日: | 2024-05-09 | 公開日: | 2017-03-01 | 識別子(ID): | 8-azanyl-4-(3-azanylpropoxy)quinoline-2-carboxylic acid |
|
![ZNA ZNA](https://data.pdbj.org/pdbjplus/data/cc/svg/ZNA.svg) | ZNA | 表記: | [[(2~{R},3~{S},4~{R},5~{R})-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-bis(oxidanyl)thiolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | 組成式: | C21 H28 N7 O13 P2 S | SMILES: | Nc1ncnc2c1ncn2C1OC(COP(=O)(O)OP(=O)(O)OCC2SC([n+]3cc(ccc3)C(N)=O)C(O)C2O)C(O)C1O | InChi: | InChI=1S/C21H27N7O13P2S/c22-17-12-19(25-7-24-17)28(8-26-12)20-15(31)13(29)10(40-20)5-38-42(34,35)41-43(36,37)39-6-11-14(30)16(32)21(44-11)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 | 定義日: | 2018-08-15 | 最終更新日: | 2024-05-08 | 公開日: | 2018-11-21 | 識別子(ID): | 1-[(2R,3R,4S,5R)-5-({[(R)-{[(S)-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxythiolan-2-yl]-3-carbamoylpyridin-1-ium (non-preferred name) |
|
![ZNB ZNB](https://data.pdbj.org/pdbjplus/data/cc/svg/ZNB.svg) | ZNB | 表記: | 2-[6-azanyl-9-[(2R,3R,4S,5R)-5-[[(azanylidene-$l^{4}-azanylidene)amino]methyl]-3,4-bis(oxidanyl)oxolan-2-yl]purin-8-yl]sulfanyl-N-[[(2R,3S,4R,5R)-5-(6-azanyl-8-bromanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl]ethanamide | 組成式: | C22 H25 Br N14 O7 S | SMILES: | OC1C(O)C(CN=[N+]=[N-])OC1n1c2ncnc(N)c2nc1SCC(=O)NCC1OC(n2c(Br)nc3c(N)ncnc32)C(O)C1O | InChi: | InChI=1S/C22H25BrN14O7S/c23-21-33-9-15(24)28-4-30-17(9)36(21)19-13(41)11(39)6(43-19)1-27-8(38)3-45-22-34-10-16(25)29-5-31-18(10)37(22)20-14(42)12(40)7(44-20)2-32-35-26/h4-7,11-14,19-20,39-42H,1-3H2,(H,27,38)(H2,24,28,30)(H2,25,29,31)/t6-,7-,11-,12-,13-,14-,19-,20-/m1/s1 | 定義日: | 2012-01-06 | 最終更新日: | 2024-05-08 | 識別子(ID): | 2-({6-amino-9-[(2R,3R,4S,5R)-5-(azidomethyl)-3,4-dihydroxyoxolan-2-yl]-9H-purin-8-yl}sulfanyl)-N-{[(2R,3S,4R,5R)-5-(6-amino-8-bromo-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}acetamide (non-preferred name) |
|
![Q41 Q41](https://data.pdbj.org/pdbjplus/data/cc/svg/Q41.svg) | Q41 | 表記: | 2-amino-3-{[(5P)-2-[(3,5-dimethoxyphenyl)methyl]-5-(4-fluoro-2-methylphenyl)-1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl]methyl}-1-methyl-1H-imidazol-3-ium | 組成式: | C30 H32 F N4 O3 | SMILES: | Cn1cc[n+](Cc2cc(c3CCN(Cc4cc(OC)cc(OC)c4)C(=O)c3c2)c2ccc(F)cc2C)c1N | InChi: | InChI=1S/C30H31FN4O3/c1-19-11-22(31)5-6-25(19)27-14-21(18-35-10-9-33(2)30(35)32)15-28-26(27)7-8-34(29(28)36)17-20-12-23(37-3)16-24(13-20)38-4/h5-6,9-16,32H,7-8,17-18H2,1-4H3/p+1 | 定義日: | 2019-09-19 | 最終更新日: | 2024-05-08 | 公開日: | 2020-01-01 | 識別子(ID): | 2-amino-3-{[(5P)-2-[(3,5-dimethoxyphenyl)methyl]-5-(4-fluoro-2-methylphenyl)-1-oxo-1,2,3,4-tetrahydroisoquinolin-7-yl]methyl}-1-methyl-1H-imidazol-3-ium |
|
![PQ3 PQ3](https://data.pdbj.org/pdbjplus/data/cc/svg/PQ3.svg) | PQ3 | 表記: | N2,N9-bis(1-methylquinolin-3-yl)-1,10-phenanthroline-2,9-dicarboxamide | 組成式: | C34 H26 N6 O2 | SMILES: | C[n+]1cc(cc2ccccc21)NC(=O)c1nc2c(cc1)ccc1ccc(nc12)C(=O)Nc1cc2ccccc2[n+](C)c1 | InChi: | InChI=1S/C34H24N6O2/c1-39-19-25(17-23-7-3-5-9-29(23)39)35-33(41)27-15-13-21-11-12-22-14-16-28(38-32(22)31(21)37-27)34(42)36-26-18-24-8-4-6-10-30(24)40(2)20-26/h3-20H,1-2H3/p+2 | 別名: | Phen-DC3 | 定義日: | 2013-11-13 | 最終更新日: | 2024-05-08 | 公開日: | 2014-01-22 | 識別子(ID): | 3,3'-[1,10-phenanthroline-2,9-diylbis(carbonylazanediyl)]bis(1-methylquinolin-1-ium) |
|
![ZAS ZAS](https://data.pdbj.org/pdbjplus/data/cc/svg/ZAS.svg) | ZAS | 表記: | 5'-azido-5'-deoxyadenosine | 組成式: | C10 H12 N8 O3 | SMILES: | Nc1ncnc2c1ncn2C1OC(C/N=[N+]=[N-])C(O)C1O | InChi: | InChI=1S/C10H12N8O3/c11-8-5-9(14-2-13-8)18(3-15-5)10-7(20)6(19)4(21-10)1-16-17-12/h2-4,6-7,10,19-20H,1H2,(H2,11,13,14)/t4-,6-,7-,10-/m1/s1 | 定義日: | 2012-01-05 | 最終更新日: | 2024-05-08 | 識別子(ID): | 5'-azido-5'-deoxyadenosine |
|
![QOJ QOJ](https://data.pdbj.org/pdbjplus/data/cc/svg/QOJ.svg) | QOJ | 表記: | 4,4'-(decane-1,10-diyl)bis(9-amino-2,3-dihydro-1H-cyclopenta[b]quinolin-4-ium) | 組成式: | C34 H44 N4 | SMILES: | Nc1c2ccccc2[n+](CCCCCCCCCC[n+]2c3ccccc3c(N)c3CCCc23)c2CCCc12 | InChi: | InChI=1S/C34H42N4/c35-33-25-15-7-9-19-29(25)37(31-21-13-17-27(31)33)23-11-5-3-1-2-4-6-12-24-38-30-20-10-8-16-26(30)34(36)28-18-14-22-32(28)38/h7-10,15-16,19-20,35-36H,1-6,11-14,17-18,21-24H2/p+2 | 定義日: | 2019-12-03 | 最終更新日: | 2024-05-08 | 公開日: | 2020-04-01 | 識別子(ID): | 4,4'-(decane-1,10-diyl)bis(9-amino-2,3-dihydro-1H-cyclopenta[b]quinolin-4-ium) |
|